Contracts › 75A50123C00042
75A50123C00042: Advance the Development of a Medical Countermeasure (MCM) Evaluation Platform That Consists of Vascular-Immune and Small Intestine-Immune Organ-On-Chip Models, Molecular Assays, Omics-Based Technologies, Advanced Analytical Methods for Biomarker Disc
Awarded to The Charles Stark Draper Laboratory, Inc. by Office of Assistant Secretary for Preparedness and Response.
$45.9Mobligated
$70.1Mpotential value
28 September 2028current end date
See modifications, all subcontractors and funding in FedSift →
| Contract | 75A50123C00042 |
|---|---|
| Awardee | The Charles Stark Draper Laboratory, Inc. |
| Awarding agency | Office of Assistant Secretary for Preparedness and Response |
| Awarding office | BARDA - ASPR / DAAPPO / BARDA DCMA |
| NAICS | 541714 Research and Development in Biotechnology (Except Nanobiotechnology) |
| PSC | AN13 Health R&D Services; Health Care Services; Experimental Development |
| Place of performance | MA |
| Offers received | 1 |
| Period of performance | 29 September 2023 to 28 September 2028 |
| Potential end | 28 September 2028 |
| Estimated recompete solicitation | ~Q2 2028 (estimate, ~6 months before expiry) |
Source: USASpending.gov (FPDS), public federal procurement data, as the agency reported it. Our record updated 03 October 2026. The solicitation date is an estimate from the end date, not a posted date.
Other expiring 541714 contracts · All expiring contracts · USASpending record